[HTML][HTML] Can cell therapies halt cytokine storm in severe COVID-19 patients?

J Ankrum - Science Translational Medicine, 2020 - science.org
Can cell therapies halt cytokine storm in severe COVID-19 patients? | Science Translational
Medicine news careers commentary Journals Science Science brought to you byGoogle …

Focusing on the cytokine storm in the battle against COVID-19: the rising role of mesenchymal-derived stem cells

A Naeem, A Waseem, AJ Siddiqui, B Ray, R Sinha… - Stem Cells, 2024 - Elsevier
A worldwide pandemic known as coronavirus disease-19 (COVID-19) has caused various
clinical complications, ranging from carriers without symptoms to acute respiratory distress …

Can mesenchymal stem cell therapy be the interim management of COVID-19?

C Bamba, SP Singh, S Choudhury - Drug discoveries & therapeutics, 2020 - jstage.jst.go.jp
COVID-19 pandemic has accounted for~ 4.3 million confirmed cases and~ 292,000 deaths
(till 12th May, 2020) across the globe since its outbreak. Several anti-viral drugs such as …

Mesenchymal stem cell research progress for the treatment of COVID-19

D Yao, H Ye, Z Huo, L Wu… - Journal of International …, 2020 - journals.sagepub.com
At the end of 2019, novel coronavirus (COVID-19) infection was detected in Wuhan City,
Hubei Province, China. The COVID-19 infection characteristics include a long incubation …

Commentary: mesenchymal stem cells: a new piece in the puzzle of COVID-19 treatment

JL Carvalho, AE Silva-Carvalho, EM Garcez… - Frontiers in …, 2021 - frontiersin.org
According to the WHO, approximately 120 million cases of COVID-19 have been confirmed
worldwide, with almost 3 million deaths recorded on April 8th, 2021 [https://covid19. who …

[HTML][HTML] Fostering mesenchymal stem cell therapy to halt cytokine storm in COVID-19

M Jeyaraman, A John, S Koshy, R Ranjan… - … et Biophysica Acta (BBA …, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) has been threatening the globe since
the end of November 2019. The disease revealed cracks in the health care system as health …

Treatment of COVID-19 by stage: any space left for mesenchymal stem cell therapy?

G Spinetti, E Avolio, P Madeddu - Regenerative Medicine, 2021 - Taylor & Francis
In many countries, COVID-19 now accounts for more deaths per year than car accidents and
even the deadliest wars. Combating the viral pandemics requires a coordinated effort to …

Clinical consideration for mesenchymal stem cells in treatment of COVID-19

KH Wu, YH Chao, TF Weng, JP Li - Current Pharmaceutical …, 2022 - ingentaconnect.com
COVID-19, which has strongly affected the 21st century, is caused by severe acute
respiratory syndrome (SARS)-CoV-2. The emergence of viral variants has rendered even …

Critical roles of cytokine storm and bacterial infection in patients with COVID-19: therapeutic potential of mesenchymal stem cells

B Arjmand, S Alavi-Moghadam, M Sarvari… - …, 2023 - Springer
The severe acute respiratory syndrome coronavirus 2 has been a shocking disaster for
healthcare systems worldwide since December 2019. This virus can affect all systems of the …

Stem cell therapy for COVID‐19: Possibilities and challenges

MS Choudhery, DT Harris - Cell biology international, 2020 - Wiley Online Library
Since its eruption in China, novel coronavirus disease (COVID‐19) has been reported in
most of the countries and territories (> 200) of the world with∼ 18 million confirmed cases …